INTERPACE BIOSCIENCES, INC. Quarterly Debt-to-equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Interpace Biosciences, Inc. quarterly Debt-to-equity history and growth rate from Q1 2012 to Q3 2024.
  • Interpace Biosciences, Inc. Debt-to-equity for the quarter ending September 30, 2024 was -44.1 %, a 12.7% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 -44.1 +6.39 +12.7% Sep 30, 2024
Q2 2024 -45.3 +5.37 +10.6% Jun 30, 2024
Q1 2024 -47.2 +8.79 +15.7% Mar 31, 2024
Q4 2023 -49 +13.7 +21.8% Dec 31, 2023
Q3 2023 -50.5 +19.7 +28.1% Sep 30, 2023
Q2 2023 -50.7 +30 +37.2% Jun 30, 2023
Q1 2023 -56 +28 +33.3% Mar 31, 2023
Q4 2022 -62.7 +23.8 +27.5% Dec 31, 2022
Q3 2022 -70.2 +20.2 +22.4% Sep 30, 2022
Q2 2022 -80.6 +17.1 +17.5% Jun 30, 2022
Q1 2022 -84 +30.8 +26.8% Mar 31, 2022
Q4 2021 -86.4 +54.2 +38.5% Dec 31, 2021
Q3 2021 -90.4 +118 +56.7% Sep 30, 2021
Q2 2021 -97.7 +386 +79.8% Jun 30, 2021
Q1 2021 -115 -2.93K -104% Mar 31, 2021
Q4 2020 -141 -459 -144% Dec 31, 2020
Q3 2020 -209 -381 -221% Sep 30, 2020
Q2 2020 -483 -586 -572% Jun 30, 2020
Q1 2020 2.81K +2.73K +3318% Mar 31, 2020
Q4 2019 318 +247 +349% Dec 31, 2019
Q3 2019 172 +110 +176% Sep 30, 2019
Q2 2019 102 +40.1 +64.4% Jun 30, 2019
Q1 2019 82.2 +13.1 +19% Mar 31, 2019
Q4 2018 71 -25.9 -26.7% Dec 31, 2018
Q3 2018 62.5 -180 -74.2% Sep 30, 2018
Q2 2018 62.3 -1.02K -94.3% Jun 30, 2018
Q1 2018 69.1 +2.51K Mar 31, 2018
Q4 2017 96.9 +2.03K Dec 31, 2017
Q3 2017 242 -1.57K -86.6% Sep 30, 2017
Q2 2017 1.09K -117 -9.74% Jun 30, 2017
Q1 2017 -2.44K -3.55K -322% Mar 31, 2017
Q4 2016 -1.93K -2.85K -309% Dec 31, 2016
Q3 2016 1.81K +990 +120% Sep 30, 2016
Q2 2016 1.2K +725 +152% Jun 30, 2016
Q1 2016 1.1K +813 +281% Mar 31, 2016
Q4 2015 923 +736 +394% Dec 31, 2015
Q3 2015 825 +709 +611% Sep 30, 2015
Q2 2015 477 +371 +347% Jun 30, 2015
Q1 2015 290 +183 +170% Mar 31, 2015
Q4 2014 187 +76.8 +69.9% Dec 31, 2014
Q3 2014 116 +4.35 +3.89% Sep 30, 2014
Q2 2014 107 +4.56 +4.46% Jun 30, 2014
Q1 2014 107 +13.8 +14.7% Mar 31, 2014
Q4 2013 110 +23.8 +27.7% Dec 31, 2013
Q3 2013 112 +29.7 +36.2% Sep 30, 2013
Q2 2013 102 +20.5 +25.1% Jun 30, 2013
Q1 2013 93.4 +13.7 +17.2% Mar 31, 2013
Q4 2012 86 Dec 31, 2012
Q3 2012 82 Sep 30, 2012
Q2 2012 81.7 Jun 30, 2012
Q1 2012 79.7 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.